Pendulum

Pendulum

Healthcare risk management consulting services

About Pendulum

Simplify's Rating
Why Pendulum is rated
D+
Rated D+ on Competitive Edge
Rated C on Growth Potential
Rated D- on Rating Differentiation

Industries

Biotechnology

Healthcare

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$26.1M

Headquarters

Seattle, Washington

Founded

2012

Overview

Pendulum specializes in risk management consulting for the healthcare industry, focusing on reducing professional liability exposure for various healthcare operations such as hospitals, aging services, and home health. The company offers a web-based enterprise risk management tool that assists organizations in optimizing their risk management strategies. Their services include risk control assessments, training, and desk-based consulting provided by experienced consultants. Unlike many competitors, Pendulum combines specialized consulting with data-driven reports and web-based tools tailored specifically for healthcare providers. The goal of Pendulum is to help healthcare organizations effectively manage and mitigate risks, ensuring safer operations and better patient care.

💵
Funded Recently
📈
Significant Headcount Growth
Simplify Jobs

Simplify's Take

What believers are saying

  • Increasing consumer interest in personalized medicine boosts Pendulum's market potential.
  • Advancements in DNA sequencing enhance Pendulum's research and development capabilities.
  • FDA's clearer guidelines streamline Pendulum's product approval process.

What critics are saying

  • Increased competition from AI-driven health solutions like Macro-Eyes.
  • Macro-Eyes' partnerships with influential organizations could overshadow Pendulum's offerings.
  • Rapid expansion of AI in healthcare may challenge Pendulum's market position.

What makes Pendulum unique

  • Pendulum Therapeutics focuses on microbiome science and DNA sequencing for therapy development.
  • The company holds 13 patents and 42 pending, showcasing strong intellectual property.
  • Pendulum's flagship product, Glucose Control, is clinically proven to lower blood sugar spikes.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$26.1M

Below

Industry Average

Funded Over

4 Rounds

Grant funding comparison data is currently unavailable. We're working to provide this information soon!
Grant Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

Flexible Work Hours

Equity

Commuter Benefits

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

6%

2 year growth

3%
Finsmes
Feb 6th, 2025
Pendulum Raises $22M In Total Funding

Pendulum, a Washington, DC-based company which specializes in real-time planning for the global supply chain, raised $22M in total funding.The investment included $11M in non-dilutive RD capital and $11M in venture capital from Lowercarbon Capital, Cross Border Impact Ventures, Decisive Point, Collab Fund, and Blaise Agüera y Arcas, VP/Fellow and CTO of Technology Society at Google.The company intends to use the funds to expand operations and its development efforts.Led by CEO Benjamin Thelonious Fels, Pendulum is advancing AI for strategic business planning so the enterprise can master supply vs. demand. Used by industry across retail, healthcare, and national security, the AI predicts demand, optimizes supply and ensures asset visibility, while the AI continuously improving on its own.Pendulum is built on foundation models for supply and demand, developed over years of MIT-grade RD.The company also announced the addition of Jean-François Gagné, co-founder of Element AI, as Chief Strategy and Product Officer. FinSMEs06/02/2025

Health Tech Arkansas
Feb 4th, 2022
macro-eyes partnered with IDA TRADING FOUNDATION PVT. LTD> on Jan 1st 18'.

2018 cohort company Macro-Eyes partnered with IDA Foundation to increase supply chain efficiency using data insights generated by the Macro-Eyes software.

Tech in Africa
Aug 5th, 2021
macro-eyes partnered with MoHS on Jan 1st 20'.

In 2020, Macro Eyes partnered with the MoHS and the Directorate of Science, Technology, and Innovation (DSTI) to create the pilot STRIATA-Infrastructure based on an intelligent health systems index that offers visibility in the health systems readiness process.

PR Newswire
Aug 3rd, 2021
macro-eyes receives financing of $2.1M in funding

Macro-Eyes has received $2.1 million in funding to expand the deployment of STRIATA in collaboration with the Ministry of Health and Sanitation (MoHS) in Sierra Leone and to expand into two additional countries.

Devex
Aug 1st, 2021
macro-eyes partners with Bill & Melinda Gates Foundation

Macro-Eyes has partnered with USAID, the U.S. Defense Department, and the Gates Foundation, which has provided the company with several grants, including one for creating an algorithm to automate the inventory counting process for family planning commodities.

Recently Posted Jobs

Sign up to get curated job recommendations

Pendulum is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Pendulum's jobs every 8 hours, so check again soon! Browse all jobs →